FDA Grants Moderna's, COVID-19 Vaccine , Full Approval.
On January 31, Moderna announced that its
COVID-19 vaccine has been granted full approval
by United States health regulators. .
On January 31, Moderna announced that its
COVID-19 vaccine has been granted full approval
by United States health regulators. .
The Associated Press reports that since its
emergency authorization over a year ago, the vaccine
has already been given to tens of millions of Americans. .
The Associated Press reports that since its
emergency authorization over a year ago, the vaccine
has already been given to tens of millions of Americans. .
In August of 2021, the FDA granted
full approval to Pfizer's vaccine.
The Associated Press reports that over
211 million Americans are fully vaccinated -
about 63% of the population. .
The Associated Press reports that over
211 million Americans are fully vaccinated -
about 63% of the population. .
Approximately 86 million people have
received at least one dose of a booster. .
According to the AP, vaccinations peaked at over
3 million doses were distributed per day last spring.
Now, daily doses average less than 750,000. .
The AP reports that the vaccine's initial
emergency approval was based on a study
that tracked 44,000 people for two months.
Moderna then continued that study
to complete longer six-month-long studies
normally required for full approval. .
The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .
The FDA reportedly monitored for serious side effects that have proven to be extremely rare. .
Last fall, the FDA delayed approving Moderna's
vaccine for use in 12 to 17 year olds as it investigated
the risk of heart inflammation in young men. .
Last fall, the FDA delayed approving Moderna's
vaccine for use in 12 to 17 year olds as it investigated
the risk of heart inflammation in young men.